Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Study reveals how one mutation causes the most common inherited intellectual disability

Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.

12 Feb 2019

NIH and partners host meeting to discuss the future of spinal cord injury research

The National Institutes of Health (NIH) and its partners will host a meeting of researchers, clinicians, patients and patient advocates to discuss spinal cord injury (SCI) research and to chart a course of future studies.

12 Feb 2019

Brain protein critical to recovery from stroke identified

Every 40 seconds, someone in the United States suffers a stroke and available therapies, such as clot busting drugs or clot removal devices, are focused on limiting the extent of brain damage.

12 Feb 2019

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

As marijuana legalization sweeps North America, use of the substance has been on the rise, and the public's attitude is shifting. An increasing number of people believe that "weed" is the safest recreational drug, one that carries health benefits that outweigh its risks.

11 Feb 2019

Early human testing of iron chelation after brain bleed shows mixed results

A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

11 Feb 2019

Home-based telerehab appears to be as effective as clinic-based therapy in restoring mobility

Home-based telerehabilitation is just as effective as clinic-based therapy at restoring arm function among stroke survivors, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.

11 Feb 2019

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

In the first study to identify specific surgical goals for the treatment of an intracerebral hemorrhage--the deadliest and most disabling type of stroke--a team of neurosurgeons found that at least 70 percent of the hemorrhage has to be removed for patients to make a meaningful recovery.

8 Feb 2019

Simple drug cocktail converts neighboring glial cells into functional new neurons

A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer's disease, and brain injuries.

8 Feb 2019

Pregnant women face greater risk of having hemorrhagic stroke, reveal studies

Pregnant women face a much greater risk of having a fatal, but less common, type of stroke caused by bleeding into the brain, according to results of two studies presented by The University of Texas Health Science Center at Houston at the International Stroke Conference 2019.

8 Feb 2019

Vilcek Foundation prizes awarded to immigrants for their work on human biology and disease

The Vilcek Foundation is pleased to announce the winners of the 2019 Vilcek Foundation Prizes for Biomedical Science, awarded to immigrants who have made significant contributions to the field. Dr. Angelika Amon will receive the $100,000 Vilcek Prize, while Drs. Amit Choudhary, Jeanne T. Paz, and Mikhail G. Shapiro will each receive the $50,000 Vilcek Prize for Creative Promise.

8 Feb 2019

Clinical study provides clear answer to debate on glucose management after stroke

Hyperglycemia, or increased glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal glucose levels.

8 Feb 2019

Removal of more blood through minimally invasive surgery improves stroke recovery

The greater the volume of blood removed from the brain via minimally invasive surgery after a cerebral hemorrhage the greater the odds of better functional recovery, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Ideal patient selection may hold promise for strokes damaging large areas of brain tissue

Mechanical clot removal has been shown to be safe and effective in stroke patients with minimal damaged brain tissue.

8 Feb 2019

Drug that reverses blood thinning effects stops acute life-threatening bleeding

A drug that reverses the blood thinning effects of factor Xa inhibitors effectively stopped acute life-threatening bleeding in patients taking a factor Xa inhibitor blood thinner drug, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Minimally-invasive surgery to remove blood from the brain associated with fewer deaths

Minimally-invasive surgery to remove blood from the brain along with intermittent dosing of a clot-busting drug after a brain bleed may not improve function better than medical therapy but it was associated with fewer deaths, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Intensive blood pressure lowering does not improve post-stroke recovery in clot-buster-treated patients

Intensive blood pressure lowering safely reduced the risk of bleeding in the brain in ischemic stroke patients being treated with clot-busting drugs, but did not improve post-stroke recovery, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Study finds underutilization of aspirin to prevent colorectal cancer in high risk patients

Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.

7 Feb 2019

High-risk sexually transmitted HPV may increase risk of cardiovascular disease

Infection with high-risk strains of the human papillomavirus, which have been linked to cancer, might increase the risk of heart and blood vessel or cardiovascular disease, especially among women with obesity or other cardiovascular risk factors, according to new research in Circulation Research, an American Heart Association journal.

7 Feb 2019

Intense glucose therapy via IV insulin did not improve stroke outcomes, study finds

Intravenous insulin did not improve stroke outcomes compared to standard blood sugar control using insulin shots - answering a worldwide debate about the best way to control glucose in stroke patients.

7 Feb 2019

Combination treatment lowers risk of ischemic stroke recurrence

Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

7 Feb 2019

Stroke News and Research

Further Reading

Study reveals how one mutation causes the most common inherited intellectual disability

NIH and partners host meeting to discuss the future of spinal cord injury research

Brain protein critical to recovery from stroke identified

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

Early human testing of iron chelation after brain bleed shows mixed results

Home-based telerehab appears to be as effective as clinic-based therapy in restoring mobility

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

Simple drug cocktail converts neighboring glial cells into functional new neurons

Pregnant women face greater risk of having hemorrhagic stroke, reveal studies

Vilcek Foundation prizes awarded to immigrants for their work on human biology and disease

Clinical study provides clear answer to debate on glucose management after stroke

Removal of more blood through minimally invasive surgery improves stroke recovery

Ideal patient selection may hold promise for strokes damaging large areas of brain tissue

Drug that reverses blood thinning effects stops acute life-threatening bleeding

Minimally-invasive surgery to remove blood from the brain associated with fewer deaths

Intensive blood pressure lowering does not improve post-stroke recovery in clot-buster-treated patients

Study finds underutilization of aspirin to prevent colorectal cancer in high risk patients

High-risk sexually transmitted HPV may increase risk of cardiovascular disease

Intense glucose therapy via IV insulin did not improve stroke outcomes, study finds

Combination treatment lowers risk of ischemic stroke recurrence

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News